NasdaqGM - Delayed Quote USD

Third Harmonic Bio, Inc. (THRD)

11.65 -0.03 (-0.26%)
At close: April 22 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
43,954.00
43,954.00
37,708.00
19,004.00
11,120.00
Operating Income
-43,954.00
-43,954.00
-37,708.00
-19,004.00
-11,120.00
Net Non Operating Interest Income Expense
13,108.00
13,108.00
2,555.00
--
--
Other Income Expense
22.00
22.00
-2.00
-10,605.00
-1,688.00
Pretax Income
-30,824.00
-30,824.00
-35,155.00
-29,609.00
-12,808.00
Net Income Common Stockholders
-30,824.00
-30,824.00
-35,155.00
-29,609.00
-12,807.00
Diluted NI Available to Com Stockholders
-30,824.00
-30,824.00
-35,155.00
-29,609.00
-12,807.00
Basic EPS
-0.78
--
-2.62
-0.80
-0.35
Diluted EPS
-0.78
--
-2.62
-0.80
-0.35
Basic Average Shares
39,645.39
--
13,426.07
26,288.58
26,288.58
Diluted Average Shares
39,645.39
--
13,426.07
26,288.58
26,288.58
Total Operating Income as Reported
-43,954.00
-43,954.00
-37,708.00
-19,004.00
-11,119.00
Total Expenses
43,954.00
43,954.00
37,708.00
19,004.00
11,120.00
Net Income from Continuing & Discontinued Operation
-30,824.00
-30,824.00
-35,155.00
-29,609.00
-12,807.00
Normalized Income
-30,824.00
-30,824.00
-35,155.00
-29,609.00
-12,807.00
Interest Income
13,108.00
13,108.00
2,555.00
--
--
Net Interest Income
13,108.00
13,108.00
2,555.00
--
--
EBIT
-43,954.00
-43,954.00
-37,708.00
-19,004.00
-11,120.00
EBITDA
-43,919.00
-43,919.00
-37,707.00
-19,004.00
-11,120.00
Reconciled Depreciation
35.00
35.00
1.00
--
--
Net Income from Continuing Operation Net Minority Interest
-30,824.00
-30,824.00
-35,155.00
-29,609.00
-12,807.00
Normalized EBITDA
-43,919.00
-43,919.00
-37,707.00
-19,004.00
-11,120.00
12/31/2020 - 9/14/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVTE Aerovate Therapeutics, Inc.
22.17
+0.54%
 
TNGX Tango Therapeutics, Inc.
7.31
0.00%
 
TYRA Tyra Biosciences, Inc.
15.50
+3.47%
 
MORF Morphic Holding, Inc.
28.50
+1.82%
 
ABVX ABIVAX Société Anonyme
15.69
+2.55%
 
TRVI Trevi Therapeutics, Inc.
2.9400
+3.70%
 
1AE.SG argenx SE
344.30
+1.56%
 
ANL Adlai Nortye Ltd.
14.42
+16.29%
 
SYRE Spyre Therapeutics, Inc.
33.30
+2.73%
 
IMCR Immunocore Holdings plc
55.82
+0.25%